SciSparc Ltd.
Developing cannabinoid-based therapies for central nervous system (CNS) disorders.
SPRC | US
Overview
Corporate Details
- ISIN(s):
- US88339A3023 (+2 more)
- LEI:
- Country:
- United States of America
- Address:
- 20 RAUL WALLENBERG STREET, TOWER A, 6971916 TEL AVIV
- Website:
- https://scisparc.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
SciSparc Ltd. is a specialty clinical-stage pharmaceutical company focused on developing therapies based on cannabinoid technologies for the treatment of central nervous system (CNS) disorders. The company's product pipeline includes multiple drug candidates in clinical trials targeting conditions such as Tourette Syndrome, Obstructive Sleep Apnea, Alzheimer’s disease and agitation, and Autism Spectrum Disorder. SciSparc also has programs in pre-clinical development for Status Epilepticus and chronic pain. The company's approach is guided by an experienced management team and a scientific advisory board to advance its therapeutic portfolio.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all SciSparc Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SciSparc Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SciSparc Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}
